|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:pp.
584–594. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reed JC: Mechanisms of apoptosis avoidance
in cancer. Curr Opin Oncol. 11:68–75. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Judson I and Kelland LR: New developments
and approaches in the platinum arena. Drugs. 59 Suppl 4:S29–S38.
2000. View Article : Google Scholar
|
|
5
|
Rosell R, Lord RV, Taron M and Reguart N:
DNA repair and cisplatin resistance in non-small-cell lung cancer.
Lung Cancer. 38:217–227. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Duan S, Tsai Y, Keng P and Chen Y, Lee SO
and Chen Y: IL-6 signaling contributes to cisplatin resistance in
non-small cell lung cancer via the up-regulation of anti-apoptotic
and DNA repair associated molecules. Oncotarget. 6:27651–27660.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang N, Qi Y, Wadham C, Wang L, Warren A,
Di W and Xia P: FTY720 induces necrotic cell death and autophagy in
ovarian cancer cells: A protective role of autophagy. Autophagy.
6:1157–1167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hung JH, Lu YS, Wang YC, Ma YH, Wang DS,
Kulp SK, Muthusamy N, Byrd JC, Cheng AL and Chen CS: FTY720 induces
apoptosis in hepatocellular carcinoma cells through activation of
protein kinase C delta signaling. Cancer Res. 68:1204–1212. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yasui H, Hideshima T, Raje N, Roccaro AM,
Shiraishi N, Kumar S, Hamasaki M, Ishitsuka K, Tai YT, Podar K, et
al: FTY720 induces apoptosis in multiple myeloma cells and
overcomes drug resistance. Cancer Res. 65:7478–7484. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Neviani P, Santhanam R, Oaks JJ, Eiring
AM, Notari M, Blaser BW, Liu S, Trotta R, Muthusamy N,
Gambacorti-Passerini C, et al: FTY720, a new alternative for
treating blast crisis chronic myelogenous leukemia and Philadelphia
chromosome-positive acute lymphocytic leukemia. J Clin Invest.
117:2408–2421. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Estrada-Bernal A, Palanichamy K, Ray
Chaudhury A and Van Brocklyn JR: Induction of brain tumor stem cell
apoptosis by FTY720: A potential therapeutic agent for
glioblastoma. Neuro-oncol. 14:405–415. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Azuma H, Takahara S, Ichimaru N, Wang JD,
Itoh Y, Otsuki Y, Morimoto J, Fukui R, Hoshiga M, Ishihara T, et
al: Marked prevention of tumor growth and metastasis by a novel
immunosuppressive agent, FTY720, in mouse breast cancer models.
Cancer Res. 62:1410–1419. 2002.PubMed/NCBI
|
|
13
|
Amaravadi RK, Lippincott-Schwartz J, Yin
XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT and White E:
Principles and current strategies for targeting autophagy for
cancer treatment. Clin Cancer Res. 17:654–666. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Degenhardt K, Mathew R, Beaudoin B, Bray
K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin S and White E: Tumor suppression by
autophagy through the management of metabolic stress. Autophagy.
4:563–566. 2008. View Article : Google Scholar :
|
|
17
|
Wang Y, Wen L, Zhao SH, Ai ZH, Guo JZ and
Liu WC: FoxM1 expression is significantly associated with
cisplatin-based chemotherapy resistance and poor prognosis in
advanced non-small cell lung cancer patients. Lung Cancer.
79:173–179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dilruba S and Kalayda GV: Platinum-based
drugs: Past, present and future. Cancer Chemother Pharmacol.
77:1103–1124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fennell DA, Summers Y, Cadranel J, Benepal
T, Christoph DC, Lal R, Das M, Maxwell F, Visseren-Grul C and Ferry
D: Cisplatin in the modern era: The backbone of first-line
chemotherapy for non-small cell lung cancer. Cancer Treat Rev.
44:42–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hung MH, Wang CY, Chen YL, Chu PY, Hsiao
YJ, Tai WT, Chao TT, Yu HC, Shiau CW and Chen KF: SET antagonist
enhances the chemosensitivity of non-small cell lung cancer cells
by reactivating protein phosphatase 2A. Oncotarget. 7:638–655.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alinari L, Baiocchi RA and Praetorius-Ibba
M: FTY720-induced blockage of autophagy enhances anticancer
efficacy of milatuzumab in mantle cell lymphoma: Is FTY720 the next
autophagy-blocking agent in lymphoma treatment? Autophagy.
8:416–417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
White C, Alshaker H, Cooper C, Winkler M
and Pchejetski D: The emerging role of FTY720 (Fingolimod) in
cancer treatment. Oncotarget. 7:23106–23127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leu WJ, Swain ShP, Chan SH, Hsu JL, Liu
SP, Chan ML, Yu CC, Hsu LC, Chou YL, Chang WL, et al:
Non-immunosuppressive triazole-based small molecule induces
anticancer activity against human hormone-refractory prostate
cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc
signaling pathways. Oncotarget. 7:76995–77009. 2016.PubMed/NCBI
|
|
24
|
Zhang N, Dai L, Qi Y, Di W and Xia P:
Combination of FTY720 with cisplatin exhibits antagonistic effects
in ovarian cancer cells: Role of autophagy. Int J Oncol.
42:2053–2059. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie Z and Klionsky DJ: Autophagosome
formation: Core machinery and adaptations. Nat Cell Biol.
9:1102–1109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takamura A, Komatsu M, Hara T, Sakamoto A,
Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K and Mizushima N:
Autophagy-deficient mice develop multiple liver tumors. Genes Dev.
25:795–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo JY, Chen HY, Mathew R, Fan J,
Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM,
Karantza V, et al: Activated Ras requires autophagy to maintain
oxidative metabolism and tumorigenesis. Genes Dev. 25:460–470.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Desai S, Liu Z, Yao J, Patel N, Chen J, Wu
Y, Ahn EE, Fodstad O and Tan M: Heat shock factor 1 (HSF1) controls
chemoresistance and autophagy through transcriptional regulation of
autophagy-related protein 7 (ATG7). J Biol Chem. 288:9165–9176.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang Y, Yan W, He X, Zhang L, Li C, Huang
H, Nace G, Geller DA, Lin J and Tsung A: miR-375 inhibits autophagy
and reduces viability of hepatocellular carcinoma cells under
hypoxic conditions. Gastroenterology. 143:177–187.e8. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pereira FV, Arruda DC, Figueiredo CR,
Massaoka MH, Matsuo AL, Bueno V and Rodrigues EG: FTY720 induces
apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic
development in vivo, and modulates the immune system. Clinics.
68:1018–1027. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi Y, Han JJ, Tennakoon JB, Mehta FF,
Merchant FA, Burns AR, Howe MK, McDonnell DP and Frigo DE:
Androgens promote prostate cancer cell growth through induction of
autophagy. Mol Endocrinol. 27:280–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng L, Lei Y, Liu R, Li J, Yuan K, Li Y,
Chen Y, Liu Y, Lu Y, Edwards CK III, et al: Pyrvinium targets
autophagy addiction to promote cancer cell death. Cell Death Dis.
4:e6142013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Patel S, Hurez V, Nawrocki ST, Goros M,
Michalek J, Sarantopoulos J, Curiel T and Mahalingam D: Vorinostat
and hydroxychloroquine improve immunity and inhibit autophagy in
metastatic colorectal cancer. Oncotarget. 7:59087–59097. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gong J, Muñoz AR, Chan D, Ghosh R and
Kumar AP: STAT3 down regulates LC3 to inhibit autophagy and
pancreatic cancer cell growth. Oncotarget. 5:2529–2541. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dando I, Donadelli M, Costanzo C, Dalla
Pozza E, D'Alessandro A, Zolla L and Palmieri M: Cannabinoids
inhibit energetic metabolism and induce AMPK-dependent autophagy in
pancreatic cancer cells. Cell Death Dis. 4:e6642013. View Article : Google Scholar : PubMed/NCBI
|
